Clinical trial
MRI Contrast Clearance Analysis for Prediction of Grading and Genotyping in Gliomas
NCT06018870 is registered in ClinicalTrials.gov with Daping Hospital and the Research Institute of Surgery of the Third Military Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRI Contrast Clearance Analysis for Prediction of Grading and Genotyping in Gliomas
- Lead sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- June 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.